Registration Statement No.333-264388 Filed Pursuant to Rule 424(b)(2)
Pricing Supplement dated May 17, 2024 to the Prospectus dated May 26, 2022, the Prospectus Supplement dated May 26, 2022 and the Product Supplement dated September 22, 2022
US$500,000.00 Senior Medium-Term Notes, Series I Digital Return Barrier Notes due August 22, 2025 Linked to the Least Performing of the NASDAQ-100 Index® and the Russell 2000® Index and the S&P 500® Index
Autocallable Variable Coupon Market-Linked Notes Based on the Worst Performing of Amgen Inc., Atlassian Corporation, F5, Inc. and Generac Holdings Inc. Due May 22, 2029
Overview
▪The notes offered by this pricing supplement are... (continue reading...)The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying prospectus, prospectus supplement and underlying supplement do not constitute an offer to sell the Notes and we are not soliciting an offer to buy the Notes in any state where the offer or sale is not permitted.
Subject to Completion. Dated May 21, 2024
Pricing Supplement... (continue reading...)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SCHEDULE 14C INFORMATION
Information Statement Pursuant to Section 14(c)
of the Securities Exchange Act of 1934
Check the appropriate box:
☒ Preliminary Information Statement
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)2))
☐ Definitive Information Statement
More SEC Filings
View Older Stories-
Form 4 SYNAPTICS Inc For: May 17 Filed by: Gupta Vikram
-
Form 4 CuriosityStream Inc. For: May 21 Filed by: WESTLEY PETER
-
Form 424B2 UBS AG
-
Form 4 OPTICAL CABLE CORP For: May 17 Filed by: HOLLAND JOHN M
-
Form 4 Vanda Pharmaceuticals For: May 17 Filed by: DUGAN RICHARD W
-
Form 424B2 BofA Finance LLC
-
Form 4/A Bowman Consulting Group For: May 13 Filed by: Bowman Gary
-
Form 144 CORE MOLDING TECHNOLOGIE Filed by: HELLMOLD RALPH O
-
Form 4 Vanda Pharmaceuticals For: May 17 Filed by: Mitchell Stephen Ray
-
Form DEF 14A Crown Electrokinetics For: May 21
-
Form 4 Vanda Pharmaceuticals For: May 17 Filed by: Ward Anne Sempowski
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form 4 Option Care Health, Inc. For: May 19 Filed by: Grashoff Christopher L.
-
Form 8-K MERIT MEDICAL SYSTEMS For: May 15
-
Form 424B2 BofA Finance LLC
-
Form 144 PARKE BANCORP, INC. Filed by: KRIPITZ JEFFREY H
-
Form 4 Option Care Health, Inc. For: May 19 Filed by: Smyser Collin
-
Form 144 MONEYLION INC. Filed by: VanWagner Adam
-
Form 8-K Inspirato Inc For: May 16
-
Form DEFA14A BlackRock Capital Alloca
-
Form 8-K WORLD ACCEPTANCE CORP For: May 15
-
Form DEFA14A SILVERBOW RESOURCES,
-
Form 4 Paragon 28, Inc. For: May 17 Filed by: Grunwald Alf
-
Form 4 RAYONIER INC For: May 17 Filed by: BASS KEITH E
-
Form DEFA14A BLACKROCK MUNIYIELD PENN
-
Form 4 MOSAIC CO For: May 20 Filed by: EBEL GREGORY L
-
Form D/A Ninety One Global Select
-
Form 4 Palladyne AI Corp. For: May 20 Filed by: THATCHER TREVOR
-
Form 4 Paragon 28, Inc. For: May 17 Filed by: Blackford Quentin S.
-
Form 4 Adtalem Global Education For: May 18 Filed by: Gangadharan Manjunath
-
Form 4 NEUROCRINE BIOSCIENCES For: May 17 Filed by: SHERWIN STEPHEN A
-
Form 4 AUBURN NATIONAL BANCORPO For: May 21 Filed by: Spencer Sandra J.
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form 8-K Achari Ventures Holdings For: May 16
-
Form 3 Savers Value Village, For: May 13 Filed by: Maher Michael W
-
Form 4 Palladyne AI Corp. For: May 20 Filed by: GARAGIC DENIS
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K CAE INC For: May 21
-
Form 4 Medpace Holdings, Inc. For: May 17 Filed by: McCarthy Cornelius P. III
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form SC TO-C ClearBridge Energy Midst Filed by: ClearBridge Energy Midstream Opportunity Fund Inc.
-
Form 4 Adtalem Global Education For: May 18 Filed by: Betz Michael
-
Form 424B2 BANK OF AMERICA CORP
-
Form 4 RAYONIER INC For: May 17 Filed by: Gonsalves Gregg A
-
Form 4 OPTICAL CABLE CORP For: May 17 Filed by: Nygren John A Jr
-
Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: Decheng Capital China Life Sciences USD Fund III, L.P.
-
Form 4 Paragon 28, Inc. For: May 17 Filed by: JOHNSON B KRISTINE
-
Form 4 MOSAIC CO For: May 20 Filed by: Gitzel Timothy S.
-
Form 4 Palladyne AI Corp. For: May 20 Filed by: SONNE STEPHEN
-
Form NT 10-Q/A EVe Mobility Acquisition For: Mar 31